| | |
C.H. Unnikrishnan 12:01 AM | June 06,2008
The company’s market value is Rs673.27 crore, based on the closing price of its shares (Rs264.55 each) on BSE on Thursday
|
|
C.H. Unnikrishnan 12:10 AM | December 15,2007
Dr Reddy’s Laboratories chairman Anji Reddy talks of drug research at the firm he founded in 1984 and the succession process in place at the company
|
|
C.H.Unnikrishnan 11:14 PM | November 26,2007
The company is currently equipped to handle services such as informatics, chemical synthesis, discovery, clinical trials
|
|
Bhuma Shrivastava and C.H. Unnikrishnan 02:13 AM | October 13,2007
Advinus Therapeutics is bullish on undertaking research and developing drugs for tuberculosis, malaria
|
|
C.H. Unnikrishnan 01:37 AM | September 28,2007
With MNCs reluctant to develop antimalarial drugs, health advocates pin hopes on a handfulof local options
|
|
C.H. Unnikrishnan 01:54 AM | September 21,2007
Company plans to go solo as WHO body opts out of four-year collaboration on key malaria drug project
|
|
06:35 AM | September 06,2007
So far, the domestic pharma industry has leveraged its scientific talent for immense success in the generics and, to a lesser extent, contract research markets
|
|
C.H. Unnikrishnan and Jeetha D’Silva 12:13 AM | March 22,2007
The country’s low-cost feature is under threat from rising costs of training and manpower shortage
|
|